Related Experiment Videos
Growth dysregulation in cancer cells
1Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
Advances in Cancer Research
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Biochemical studies on active transport.
The Journal of general physiology·2009
Differential display of mRNA by PCR.
Current protocols in molecular biology·2008
Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target.
Journal of cellular biochemistry·2004
Apoptosis in non-proliferating cells: implications for viral infection and tumourigenesis.
Apoptosis : an international journal on programmed cell death·2003
Expression of cyclins E1 and E2 during mouse development and in neoplasia.
Proceedings of the National Academy of Sciences of the United States of America·2001
The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.
Proceedings of the National Academy of Sciences of the United States of America·2001
Cancer immunotherapy with oncolytic myxoma virus.
Advances in cancer research·2026
Advancing clinical translation of oncolytic adenoviruses.
Advances in cancer research·2026
Operation oncolysis: Reoviruses in the theater of cancer war.
Advances in cancer research·2026
AAV vectors for cancer gene therapy.
Advances in cancer research·2026
Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer.
Advances in cancer research·2026
The Challenges Experienced by Oncology Nurses during the COVID-19 Pandemic: A Systematic Review.
Iranian journal of nursing and midwifery research·2026
FSCN1 promotes rheumatoid arthritis progression via inhibiting TRIM38-mediated ubiquitination of IGF2BP1 in fibroblast-like synoviocytes.
Arthritis & rheumatology (Hoboken, N.J.)·2026